Tag: Covid-19
-
Economic Model IDs Pandemic Business Opening Risks
As communities try to manage their economies during the Covid-19 pandemic, three economists offer a model to help decide which businesses to open after shutting down.
-
Covid-19 Antibody Cocktail to Begin Clinical Trial
A combination of two synthetic antibodies, with an enhanced infection-blocking design for preventing and treating Covid-19 infections, is set to begin a clinical trial.
-
Challenge Seeks Class of 2020 Covid-Inspired Companies
A new challenge competition aims to recognize start-up companies founded by university students getting their undergraduate degrees this year.
-
Cancer Drug Technology Licensed for Covid-19
A biotechnology company is licensing medical research discoveries from university labs first designed for treating cancer as a potential Covid-19 therapy.
-
Weak Covid-19 App Privacy Found, Risk Software in Works
An analysis of mobile apps tracking Covid-19 cases and symptoms finds most lack basic privacy protections, despite collecting personal identifying information.
-
Covid-19 Vaccine for Lower-Income Regions Underway
Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries.
-
Infographic – High Hopes for Covid-19 Therapy, Vaccine
Sizeable majorities of Americans expect to see treatments and a vaccine for Covid-19 in the next 12 months, but also another outbreak of the disease.
-
Industry, Univ. Labs Partner on Covid-19 Therapy
Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine.
-
Data Company Building Covid-19 Early Warning System
An initiative is underway to detect early signs of Covid-19 infections from individuals’ activity and sleep data collected with smartphones and wearable devices.
-
Large-Scale Antibody Screening Device in Development
A system to quickly screen for human antibodies that neutralize SARS-CoV-2 or other infectious viruses is being developed at Texas A&M University.